1. Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway
    Dong-Dong Tian et al, 2017 CrossRef
  2. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma
    Han Wang et al, 2017, European Journal of Pharmacology CrossRef
  3. Oridonin inhibition and miR‑200b‑3p/ZEB1 axis in human pancreatic cancer.
    Zhifang Gui et al, 2017, Int J Oncol CrossRef
  4. HDAC8 Prevents Anthrax Lethal Toxin-induced Cell Cycle Arrest through Silencing PTEN in Human Monocytic THP-1 Cells
    , 2017, Toxins CrossRef
  5. Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN
    Wenting Deng et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  6. Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
    Barbara Guerra et al, 2019, Pharmaceuticals CrossRef
  7. The NLRP3 Inflammasome as a Pharmacological Target
    Carlo Marchetti, 2019, Journal of Cardiovascular Pharmacology CrossRef
  8. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
  9. Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
    Pavel Spirin et al, 2017, Oncotarget CrossRef
  10. Preparation of oridonin nanocrystals and study of their endocytosis and transcytosis behaviours on MDCK polarized epithelial cells
    Huagang Sheng et al, 2020, Pharmaceutical Biology CrossRef
  11. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling
    Rong-Xing Liu et al, 2018, Int J Oncol CrossRef
  12. Oridonin enhances the radiosensitivity of lung cancer cells by upregulating Bax and downregulating Bcl-2.
    Sirui Li et al, 2018, Exp Ther Med CrossRef
  13. Oridonin enhances γ‑globin expression in erythroid precursors from patients with β‑thalassemia via activation of p38 MAPK signaling
    Lishan Guo et al, 2019, Mol Med Report CrossRef
  14. Oridonin inhibits migration, invasion, adhesion and TGF‑β1‑induced epithelial‑mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK‑3β signaling pathway
    Chun‑Yu Li et al, 2017, Oncol Lett CrossRef
  15. PTEN inhibits non‑small cell lung cancer cell growth by promoting G0/G1 arrest and cell apoptosis
    Libao Liu et al, 2018, Oncol Lett CrossRef
  16. Plant Extracts and their Secondary Metabolites as Modulators of Kinases
    Muhammad Shoaib Ali Gill et al, 2020, CTMC CrossRef
  17. AMPK/mTOR/ULK1 Axis-Mediated Pathway Participates in Apoptosis and Autophagy Induction by Oridonin in Colon Cancer DLD-1 Cells

    Heqi Bu et al, 2020, OTT CrossRef
  18. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A
    Hong-Chuan Liu et al, 2020, ACAMC CrossRef
  19. Targeting AKT with Oridonin Inhibits Growth of Esophageal Squamous Cell Carcinoma In Vitro and Patient-Derived Xenografts In Vivo
    Mengqiu Song et al, 2018, Mol Cancer Ther CrossRef
  20. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.
    Xiang Li et al, 2021, Front Pharmacol CrossRef
  21. Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
    Shusuke Yasuda et al, 2022, Biochemical and Biophysical Research Communications CrossRef
  22. New and Emerging Targeted Therapies for Advanced Breast Cancer
    Kristie H. Lau et al, 2022, IJMS CrossRef
  23. CXCL10-coronated thermosensitive “stealth” liposomes for sequential chemoimmunotherapy in melanoma
    Xiaofei Xin et al, 2022, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  24. Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states
    Hedieh Sattarifard et al, 2023, Biochem. Cell Biol. CrossRef
  25. null
    Muhammad Ali Qureshi et al, 2024 CrossRef